Skip to main content
Journal ArticleOPEN ACCESS

Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer

  • Jung H
  • Bischof A
  • Ebsworth K
  • et al.
Journal for ImmunoTherapy of Cancer (2015) 3(S2)
DOI: 10.1186/2051-1426-3-s2-p227
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Meeting abstracts Trafficking and expansion of myeloid derived suppressor cells (MDSCs) plays a major role in immune suppression of tumor. MDSCs express chemokine receptors which likely mediate their recruitment to the tumor microenvironment. Suppression of T cells is also mediated by the

Cite

CITATION STYLE

APA

Jung, H., Bischof, A., Ebsworth, K., Ertl, L., Schall, T., & Charo, I. (2015). Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer. Journal for ImmunoTherapy of Cancer, 3(S2). https://doi.org/10.1186/2051-1426-3-s2-p227

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free